2021-04-27T15:13:06-05:00 2020-06-30 593070669 MSL PA 255 S ORANGE AVENUE SUITE 600 ORLANDO FL 32801 990 2019-07-01 010554709 FLORIDA PROTON THERAPY INSTITUTE INC FLOR 9045881800 2015 NORTH JEFFERSON STREET JACKSONVILLE FL 32206 STUART KLEIN EXECUTIVE DIRECTOR 9045881800 2021-04-27 1 COURTNEY HOGBEN P01619105 4077405400 2019 2022-09-23 18:48:47Z STUART KLEIN 2015 NORTH JEFFERSON STREET JACKSONVILLE FL 32206 48092587 0 X WWW.FLORIDAPROTON.ORG X 2001 FL TO PROVIDE CANCER TREATMENT SERVICES, EDUCATIONAL PROGRAMS, AND TRAINING OPPORTUNITIES. 10 9 175 9 0 0 492975 1216982 46315688 42091302 998749 806034 1085465 921106 48892877 45035424 16240 2050 0 0 12645068 13178124 0 38929 38929 32107221 29963232 44768529 43182335 4124348 1853089 160347827 157333912 82981385 79532616 77366442 77801296 X THE ORGANIZATION PROVIDES CANCER TREATMENT SERVICES, EDUCATIONAL PROGRAMS, AND TRAINING OPPORTUNITIES TO PROMOTE BASIC AND CLINICAL RESEARCH RELATED TO CANCER TREATMENTS AND TREATMENT PROGRAMS. 0 0 41330248 2050 43026634 THE PRIMARY ACTIVITY OF THE INSTITUTE IS TO PROVIDE PROTON AND CONVENTIONAL RADIATION THERAPY CANCER TREATMENT IN FACILITIES LOCATED IN JACKSONVILLE, FLORIDA.SEE SCHEDULE O FOR ADDITIONAL INFORMATION. SINCE COMMENCING CLINICAL OPERATIONS IN AUGUST OF 2006, THE INSTITUTE HAS CONTINUED TO FOCUS ITS RESOURCES ON FULFILLING ITS TRIPARTITE MISSION OF CLINICAL SERVICE, RESEARCH AND EDUCATION. TO DATE, THE INSTITUTE HAS PROVIDED CANCER TREATMENT SERVICES TO OVER 9,200 PATIENTS. THE CLINICAL PROGRAMS FOCUS ON MULTIPLE DISEASE SITES INCLUDING, BUT NOT LIMITED TO: CANCERS OF THE BRAIN AND CENTRAL NERVOUS SYSTEM, PROSTATE, SOFT TISSUES, EYE, BREAST, LUNG AND PANCREAS. THE INSTITUTE CURRENTLY OPERATES THE WORLD'S LARGEST PEDIATRIC PROGRAM UTILIZING PROTON THERAPY. SUPPLEMENTAL RESOURCES DEDICATED TO THE PEDIATRIC POPULATION INCLUDE: A FULL-TIME PLAY THERAPIST, A PEDIATRIC SOCIAL WORKER AND ART THERAPY STAFF. ALSO, PEDIATRIC PATIENTS ARE PROVIDED VARIOUS EDUCATIONAL AND "FUN" EVENTS SUPPORTED BY: THE LOCAL ZOO, SCIENCE LADY, FIRE DEPARTMENT, ETC. A CORNERSTONE OF THE INSTITUTE'S MISSION INCLUDES CLINICAL RESEARCH. CURRENTLY, THE INSTITUTE HAS A TOTAL OF 32 CLINICAL TRIAL STUDIES THAT HAVE BEEN COMPLETED OR ARE CURRENTLY OPEN FOR PATIENT ACCRUAL. APPROXIMATELY 87% OF THE INSTITUTE'S PATIENTS PARTICIPATE IN ONE OF THE CLINICAL TRIAL PROGRAMS OR OUTCOME STUDIES. LIKEWISE, THE INSTITUTE HAS DEVELOPED MULTIPLE EDUCATIONAL OPPORTUNITIES INCLUDING POST GRADUATE FELLOWSHIP TRAINING PROGRAMS IN PROTON RADIATION, PEDIATRICS AND IN MEDICAL PHYSICS. ALSO, THE INSTITUTE PROVIDES ONSITE TRAINING FOR SEVERAL RADIATION THERAPIST TRAINING PROGRAMS AND CHILD LIFE SPECIALIST SOCIAL WORKER PROGRAMS.AS A CANCER CENTER OF EXCELLENCE AND ACCREDITED RADIATION ONCOLOGY CENTER THROUGH THE AMERICAN COLLEGE OF RADIOLOGY (ACR), THE INSTITUTE CONTINUED TO PROVIDE OPTIMAL PATIENT CARE AND SERVICES. ALSO, THE INSTITUTE CONTINUES TO IMPROVE ITS ART-IN-MEDICINE PROGRAM, YOGA CLASSES, EDUCATIONAL ACTIVITIES, AND SURVIVORSHIP PROGRAM. THESE PROGRAMS ARE AIMED TO INCREASE THE HEALING ENVIRONMENT AND CULTURE CREATED AT THE INSTITUTE. PRIMARILY, THESE PROGRAMS ENHANCE WELLNESS, RELAXATION, PAIN MANAGEMENT, AND DECREASE ANXIETY AND STRESS IN PATIENTS AND CAREGIVERS UNDERGOING CANCER CARE AT THE INSTITUTE. THE PROGRAM HAS BEEN SO SUCCESSFUL THAT 99% OF PATIENTS WOULD DEFINITELY RECOMMEND THE INSTITUTE'S TREATMENT AND SERVICES.AS A HEALTHCARE ORGANIZATION, THE INSTITUTE HAS WORKED TIRELESSLY TO CREATE A CULTURE OF SAFETY FOR PATIENTS, CAREGIVERS AND STAFF TO MINIMIZE COVID TRANSMISSIONS. THIS INCLUDES PROMOTING PHYSICAL DISTANCING WITH A REARRANGED LOBBY, EMPLOYEE WORKSPACES AND PROVIDING TELEWORK OPTIONS TO ITS PATIENTS AND STAFF. THE INSTITUTE HAS PROVIDED ITS FRONTLINE STAFF WITH THE MOST PROTECTIVE PPE POSSIBLE, (INCLUDING SCRUBS, N95 MASK AND EYE PROTECTION) AS WELL AS A DESIGNATED SPECIAL CLINICAL STAFF TEAM TO PROVIDE CARE FOR ANY PATIENT WITH COVID OR SUSPECTED TO HAVE COVID. THIS INCLUDES SYSTEM WIDE PROTOCOLS AND SPECIALIZED TRAINING FOR THE PROPER BUT SAFE CARE OF THE PATIENT AND STAFF MEMBERS. WHILE SOME PATIENT SERVICES HAVE BEEN POSTPONED DURING THE COVID PERIOD, ADDITIONAL CONTACT EFFORTS HAVE BEEN ESTABLISHED TO STAY CONNECTED AND SERVICE PATIENTS. THE INSTITUTE IS RECOGNIZED AS THE WORLD LEADER IN PEDIATRIC PROTON RADIATION THERAPY AND CONTINUALLY PROVIDES TREATMENT TO PATIENTS FROM MANY COUNTRIES AROUND THE WORLD AS WELL AS MANY STATES WITHIN THE USA. THE ADULT PROGRAMS ARE EQUALLY RECOGNIZED FOR THE TREATMENT OPTIONS AND CONTINUED CANCER RESEARCH. CURRENTLY, THE INSTITUTE IS COLLECTING DATA ON RESEARCH STUDIES, EITHER FOR ITS OWN MISSION OR PARTICIPATING WITH OTHER NOTED MEDICAL INSTITUTIONS, SUCH AS ST. JUDE'S CHILDREN'S HOSPITAL, MASSACHUSETTS GENERAL HOSPITAL, ETC. IN FISCAL YEAR 2020 THE INSTITUTE'S PROFESSIONAL STAFF PUBLISHED 44 STUDIES IN MAJOR MEDICAL PUBLICATIONS.DURING THE YEAR, THE INSTITUTE CONTINUED ITS $44 MILLION EXPANSION PROGRAM THAT WILL INCREASE THE CAPACITY FOR THE NUMBER OF PATIENTS TREATED AT THE JACKSONVILLE FACILITY AND THE TYPES OF CANCERS IT IS ABLE TO TREAT. THE PROJECT INCLUDES THE ADDITION OF A NEW PROTON SYSTEM, BUILDING ADDITION, SYSTEM UPGRADES TO ITS PRESENT SYSTEM AND IMPROVEMENTS TO ITS TREATMENT AND PLANNING TECHNOLOGY. 41330248 1 1 0 0 0 0 0 0 0 1 1 1 0 1 1 1 1 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 38 0 1 175 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 9 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 1 1 X TOMMIE ALLEN 9045881800 2015 NORTH JEFFERSON STREET JACKSONVILLE FL 32206 NANCY P MENDENHALL MD TRUSTEE/MEDICAL DIRECTOR 40.00 X X 675696 0 22916 STUART KLEIN EXECUTIVE DIRECTOR 40.00 X 418166 0 30559 KEVIN KIRBY DIRECTOR OF CLINICAL DOSIMETRY 40.00 X 181293 0 18495 TREVOR FLEMING DIRECTOR OF TECHNICAL SERVICES 40.00 X 177128 0 19890 DEBBIE LOUIS DIRECTOR OF DOSIMETRIST RESEARCH 40.00 X 180957 0 11455 EMMA VIVIERS TREATMENT PLANNING PHYSICIST 40.00 X 150826 0 19101 KATHY MCINTIRE DIRECTOR OF BILLING SERVICES 40.00 X 158903 0 7648 WILLIAM GLIDDEN LEAD DOSIMETRIST 40.00 X 145906 0 13922 TOMMIE ALLEN CHIEF FINANCIAL OFFICER 40.00 X 147253 0 10397 BRADLEE ROBBERT DIRECTOR OF OPERATIONS 40.00 X 137545 0 18703 NATALIYA GETMAN LEAD DOSIMETRIST 40.00 X 136382 0 15374 ERNEST ST JOHN CHIEF RADIATION THERAPIST 40.00 X 131926 0 18534 ADRIAN TYNDALL MD MPH CHAIRMAN/PRESIDENT 0.30 X X 0 0 0 PAUL OKUNIEFF PHD SECRETARY/TREASURER 0.30 X X 0 0 0 YVES JONGEN PHD TRUSTEE 0.30 X 0 0 0 JONATHAN D LICHT MD TRUSTEE 0.30 X 0 0 0 KATHERINE PEARSON-PEYTON MD TRUSTEE 0.30 X 0 0 0 LEON HALEY JR MD TRUSTEE 0.30 X 0 0 0 DR CHARLES LANE TRUSTEE 0.30 X 0 0 0 DANIEL M EDELMAN TRUSTEE 0.30 X 0 0 0 KENNETH R HAMILTON TRUSTEE 0.30 X 0 0 0 2641981 0 206994 23 0 1 1 UF DEPARTMENT OF RADIATION ONCOLOGY PO BOX 100385 GAINESVILLE FL 32610 STAFFING PROVIDER 9941559 IBA PROTON THERAPY INC 151 HEARTLAND BLVD EDGEWOOD NY 11717 EQUIPMENT MAINTENANCE 4298618 SHEPHERD 1301 RIVERPLACE BLVD SUITE 1100 JACKSONVILLE FL 32207 ADVERTISING SERVICES 2288713 RC BILLING PO BOX 659831-MSC 224 SAN ANTONIO TX 78265 BILLING SERVICES 1200574 GILBANE BUILDING COMPANY 7 JACKSON WALKWAY PROVIDENCE RI 02903 CONSTRUCTION SERVICES 757458 15 128063 656827 432092 1216982 PATIENT CARE REVENUE 621500 40885992 40885992 SHARED SERVICE REVENUE 621500 1094910 1094910 RESEARCH REVENUE 621500 110400 110400 42091302 645520 645520 3186801 3026287 160514 160514 160514 16650 128063 30876 -14226 -14226 OPERATION & MAINTENANCE REIMBURSE 900099 845174 845174 OTHER INCOME 900099 90158 90158 935332 45035424 43026634 0 791808 X 2050 2050 1014197 936693 77504 10050405 9441598 608807 269173 250959 18214 1165489 1086627 78862 678860 632925 45935 269899 269899 38062 38062 38929 38929 10619415 10501415 118000 1426077 1283469 142608 323719 119526 204193 306680 282187 24493 8346800 8263331 83469 12485 12485 109128 109128 1748108 1711133 36975 4387681 4384046 3635 456036 451476 4560 SUPPLIES 1827101 1781644 45457 PATIENT PROGRAMS 60222 60222 TRAINING 31819 31819 43182335 41330248 1813158 38929 2685288 3730422 4003672 4437028 3890109 2792833 2656212 113584797 44685264 69593942 68899533 36344927 4576352 41467546 15454823 29038986 28110066 160347827 157333912 4921385 3596229 75318000 69625729 0 2116658 2742000 4194000 82981385 79532616 X 76627308 76887062 739134 914234 77366442 77801296 160347827 157333912 X 1853089 33765 -1452000 X X 0 1 X 1 0 X 338925 764665 327489 492975 1216982 3141036 52021447 49847768 52646136 46315688 42091302 242922341 170771 280666 145428 150452 16650 763967 52531143 50893099 53119053 46959115 43324934 246827344 0 0 0 246827344 156964 236030 485130 970589 645520 2494233 156964 236030 485130 970589 645520 2494233 6735214 945201 985690 966816 935332 10568253 59423321 52074330 54589873 48896520 44905786 259889830 0.94970 0.95210 0.00960 0.00750 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: O M UNIVERSITY OF FLORIDA - 2015 AMOUNT: $ 845,174. 2016 AMOUNT: $ 845,174. 2017 AMOUNT: $ 845,174. 2018 AMOUNT: $ 845,174. 2019 AMOUNT: $ 845,174. OTHER INCOME - 2015 AMOUNT: $ 5,890,040. 2016 AMOUNT: $ 100,027. 2017 AMOUNT: $ 140,516. 2018 AMOUNT: $ 121,642. 2019 AMOUNT: $ 90,158. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 624982 175100 800082 614982 10000 624982 604832 10150 614982 149519 455313 604832 149019 500 149519 1.00000 1 0 2296957 1009652 1287305 108588395 42983713 65604682 2699445 691899 2007546 68899533 MONEY MARKET FUNDS 6441289 F INVESTMENT IN FLORIDA SHORT-TERM FIXED INCOME FUND, LP 35026257 F 41467546 DEPOSITS 114263 INTEREST IN LEASEHOLD 24355478 OTHER RECEIVABLES 3640325 28110066 FAIR VALUE OF INTEREST RATE SWAP AGREEMENT 4194000 4194000 X 43578260 33765 -1490929 -1457164 45035424 0 45035424 43143406 0 43143406 38929 38929 43182335 PART V, LINE 4: ENDOWMENT FUNDS ARE ESTABLISHED AS A MEANS TO PROVIDE FUTURE CASH FLOWS FOR OPERATIONS AND OTHER PURPOSES DESIGNATED BY THE INSTITUTE'S DONORS. PART X, LINE 2: THE INSTITUTE IS RECOGNIZED AS AN ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX UNDER 501(A) AS ENTITIES DESCRIBED IN SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE, EXCEPT FOR TAXES ON INCOME FROM ACTIVITIES UNRELATED TO ITS EXEMPT PURPOSES. THE INSTITUTE DOES NOT HAVE ANY MATERIAL, UNRECOGNIZED TAX POSITIONS THAT SHOULD BE RECOGNIZED IN THE FINANCIAL STATEMENTS FOR THE YEARS ENDED JUNE 30, 2020 OR 2019. PART XI, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSE -38,929. CHANGE IN FAIR VALUE OF INTEREST RATE SWAP -1,452,000. PART XII, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EXPENSE 38,929. PART V, LINE 3A(I) THE FILING ORGANIZATION'S ENDOWMENT FUNDS ARE HELD AND ADMINISTERED BY THE UNIVERSITY OF FLORIDA FOUNDATION (THE FOUNDATION). THE FOUNDATION IS AN UNRELATED NOT-FOR-PROFIT ENTITY WHOSE PRIMARY PURPOSE IS TO RAISE FUNDS TO SUPPORT THE UNIVERSITY AND OTHER CHARITABLE ORGANIZATIONS, INCLUDING THE INSTITUTE. THE INSTITUTE HAS RECOGNIZED ITS INTEREST IN CONTRIBUTIONS RECEIVED AND HELD BY THE FOUNDATION THAT HAVE BEEN DESIGNATED BY THE DONOR FOR THE BENEFIT OF THE INSTITUTE. X 1 UNIVERSITY OF FLORIDA FOUNDATION INC PO BOX 14425 GAINESVILLE FL 32604 ADMINISTRATIVE SERVICES FOR FUNDRAISING ACTIVITIES 1 144713 38929 105784 144713 38929 105784 GOLF TOURNAMENT 144713 128063 16650 22697 500 7679 144713 128063 16650 22697 500 7679 30876 -14226 0 0 0 0 0 0 0 0 0 NANCY P MENDENHALL MD TRUSTEE/MEDICAL DIRECTOR 620963 0 45133 0 9600 0 21847 0 1069 0 698612 0 0 0 STUART KLEIN EXECUTIVE DIRECTOR 402832 0 9211 0 6123 0 14826 0 15733 0 448725 0 0 0 KEVIN KIRBY DIRECTOR OF CLINICAL DOSIMETRY 181293 0 0 0 0 0 5437 0 13058 0 199788 0 0 0 TREVOR FLEMING DIRECTOR OF TECHNICAL SERVICES 177128 0 0 0 0 0 5312 0 14578 0 197018 0 0 0 DEBBIE LOUIS DIRECTOR OF DOSIMETRIST RESEARCH 180957 0 0 0 0 0 5427 0 6028 0 192412 0 0 0 EMMA VIVIERS TREATMENT PLANNING PHYSICIST 150826 0 0 0 0 0 4523 0 14578 0 169927 0 0 0 KATHY MCINTIRE DIRECTOR OF BILLING SERVICES 158903 0 0 0 0 0 4838 0 2810 0 166551 0 0 0 WILLIAM GLIDDEN LEAD DOSIMETRIST 145906 0 0 0 0 0 4375 0 9547 0 159828 0 0 0 TOMMIE ALLEN CHIEF FINANCIAL OFFICER 147253 0 0 0 0 0 4411 0 5986 0 157650 0 0 0 BRADLEE ROBBERT DIRECTOR OF OPERATIONS 137545 0 0 0 0 0 4125 0 14578 0 156248 0 0 0 NATALIYA GETMAN LEAD DOSIMETRIST 136382 0 0 0 0 0 4090 0 11284 0 151756 0 0 0 ERNEST ST JOHN CHIEF RADIATION THERAPIST 131926 0 0 0 0 0 3956 0 14578 0 150460 0 0 0 SCHEDULE J, PART I, LINE 3 THE FILING ORGANIZATION'S EXECUTIVE DIRECTOR, STUART KLEIN, WAS COMPENSATED BY THE UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE, AN UNRELATED ENTITY, FOR SERVICES PROVIDED TO THE FILING ORGANIZATION. THE EXECUTIVE DIRECTOR'S COMPENSATION WAS DETERMINED ACCORDING TO THE UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE'S POLICIES AND PROCEDURES. FORM 990, PART VII, LINE 5 THE FILING ORGANIZATION'S EXECUTIVE DIRECTOR, STUART KLEIN, AND THE MEDICAL DIRECTOR, DR. NANCY MENDENHALL, WERE COMPENSATED BY THE UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE, AN UNRELATED ENTITY, FOR SERVICES PROVIDED TO THE FILING ORGANIZATION. COMPENSATION FOR THESE INDIVIDUALS HAS BEEN REPORTED IN PART II, ROW (I) ACCORDING TO IRS GUIDELINES. A JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 2012-08-01 25580000 SEE SUPPLEMENTAL INFORMATION - PART V 1 0 0 B JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 2012-08-01 7000000 SEE SUPPLEMENTAL INFORMATION - PART V 1 0 0 C JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 46936FAN8 2017-08-18 27250000 SEE SUPPLEMENTAL INFORMATION - PART V 0 0 0 D JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 46936FAN8 2017-08-18 27250000 SEE SUPPLEMENTAL INFORMATION - PART V 0 0 0 A 8810000 25580000 2006036 20344527 2012 1 0 1 1 B 2948000 7000000 501509 5298632 2012 1 0 1 1 C 1000000 27240000 283371 7839900 19116729 2017 1 0 1 1 D 3400000 27225000 283371 7824900 19116729 1 0 1 1 A 0 0 0 0 0 0 0 B 0 0 0 0 0 0 0 C 0 0 0 0 0 0 0 D 0 0 0 0 0 0 0 A 0 0 0 1 1 0 0 0 1 B 0 0 0 1 1 0 0 0 1 C 0 1 0 0 1 0 0 0 1 D 0 1 0 0 1 0 0 0 1 A 1 B 1 C 1 D 1 DATE REBATE COMPUTATION PERFORMED ISSUER NAME: JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION DATE THE REBATE COMPUTATION WAS PERFORMED: 06/30/2017 ISSUER NAME: JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION DATE THE REBATE COMPUTATION WAS PERFORMED: 06/30/2017 SCHEDULE K PART I COLUMN F LINES A & B THE SERIES 2007B BONDS AND SERIES 2017 BONDS WERE ISSUED PURSUANT TO THE INDENTURE, WHICH PROVIDES, AMONG OTHER THINGS, THAT THE INSTITUTE MAINTAIN CERTAIN MINIMUM FINANCIAL RATIOS. MANAGEMENT IS NOT AWARE OF ANY VIOLATIONS OF THE COVENANTS AT JUNE 30, 2020 AND 2019. THE SERIES 2007B BONDS AND SERIES 2017 BONDS ARE COLLATERALIZED BY EQUIPMENT, MACHINERY, AND OTHER PERSONAL PROPERTY, INCLUDING THE INSTITUTE'S GROSS REVENUES, AS DEFINED IN THE INDENTURE. ON AUGUST 1, 2012, AS PART OF A MODIFICATION OF THE SERIES 2007B BONDS, THE INSTITUTE REPAID $12,110,000 OF THE SERIES 2007B BONDS TO REDUCE THE REMAINING UNPAID PRINCIPAL BALANCE TO $32,580,000. THE SERIES 2007B BONDS WERE THEN REPLACED WITH (A) $25,580,000 OF SERIES 2007B-1 BONDS AND (B) $7,000,000 OF SERIES 2007B-2 BONDS. SCHEDULE K PART I COLUMN F LINES C & D ON AUGUST 18, 2017, THE INSTITUTE ISSUED SERIES 2017A BONDS AND SERIES 2017B BONDS PURSUANT TO AN INDENTURE (COLLECTIVELY, THE "SERIES 2017 BONDS") AS PART OF A REFINANCING OF THE 2007A BONDS. THE PROCEEDS OF THE SERIES 2017 BONDS, ALONG WITH THE REMAIN-ING AVAILABLE BALANCE OF THE SERIES 2007A BOND FUND AND DEBT SERVICE RESERVE FUND, WERE USED TO (A) REFUND THE REMAINING AMOUNTS DUE ON AND EXTINGUISH THE SERIES 2007A BONDS ON SEPTEMBER 1, 2017, (B) PAY THE COSTS OF ISSUANCE, AND (C) PROVIDE FUNDING FOR THE INSTITUTE'S PLANNED EXPANSION. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 WILL FIRST BE REVIEWED AND APPROVED BY THE CHIEF FINANCIAL OFFICER. SUBSEQUENT TO THE CFO'S APPROVAL, FORM 990 WILL BE PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL PRIOR TO FILING IT WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION'S GOVERNING BODY MONITORS AND ENFORCES COMPLIANCE WITH THE CONFLICT OF INTEREST POLICY ANNUALLY. THE GOVERNING BODY REVIEWS ACTUAL CONFLICTS, IF ANY, THAT ARE IDENTIFIED BY THE ANNUAL DISCLOSURE PROCESS AND PROHIBITS OFFICERS AND DIRECTORS FROM VOTING ON MATTERS WHERE ACTUAL CONFLICTS OF INTEREST EXIST. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE DIRECTOR AND MEDICAL DIRECTOR'S COMPENSATION IS CONTROLLED AND APPROVED BY THE UNIVERSITY OF FLORIDA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC AND ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONTRACTED HEALTHCARE SERVICES: PROGRAM SERVICE EXPENSES 8,858,069. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 8,858,069. BILLING AND COLLECTION SERVICES: PROGRAM SERVICE EXPENSES 1,067,688. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,067,688. OTHER PURCHASED SERVICES: PROGRAM SERVICE EXPENSES 575,658. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 575,658. CONSULTING SERVICES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 118,000. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 118,000. FORM 990, PART XI, LINE 9: CHANGE IN FAIR VALUE OF INTEREST RATE SWAP -1,452,000. FORM 990, PART XII, LINE 2C OVERSIGHT OF AUDIT AND SELECTION OF INDEPENDENT ACCOUNTANT: THE GOVERNING BODY IS RESPONSIBLE FOR THE SELECTION, MONITORING AND EVALUATION OF AN INDEPENDENT AUDIT FIRM AND OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS. THERE WAS NO CHANGE IN THIS PROCESS FROM THE PRIOR YEAR. GENERAL DISCLOSURE CHARITY CARE: THE INSTITUTE PROVIDES CARE TO PATIENTS WHO MEET CERTAIN CRITERIA UNDER ITS CHARITY CARE POLICY WITHOUT CHARGE OR AT AMOUNTS LESS THAN ITS ESTABLISHED RATES. BECAUSE THE INSTITUTE DOES NOT PURSUE COLLECTION OF AMOUNTS DETERMINED TO QUALIFY AS CHARITY CARE, THEY ARE NOT REPORTED AS NET PATIENT SERVICE REVENUE. DURING THE YEAR ENDED JUNE 30, 2020, THE INSTITUTE RECOGNIZED WRITE-OFFS FROM CHARITY CARE OF APPROXIMATELY $787,000. THE DIRECT AND INDIRECT COSTS OF THESE SERVICES WERE APPROXIMATELY $210,000. THE INSTITUTE PARTICIPATES IN SEVERAL LOCAL/NATIONAL CANCER AND CHILDREN WELLNESS FUND RAISING EVENTS AS SPONSORS AND PARTICIPANTS. THE INSTITUTE ALSO PROVIDES SEVERAL EDUCATIONAL SEMINARS TO COMMUNITIES WITHIN THE SOUTHEAST RELATED TO CANCER PREVENTION AND TREATMENT OPTIONS. IN ADDITION, WEEKLY EDUCATIONAL OPPORTUNITIES ARE AVAILABLE TO PATIENTS, CAREGIVERS AND INVITED GUESTS RELATED TO CARE DURING AND AFTER TREATMENT.